Benzinga | Dec 21, 2020 09:54AM EST

A Look Into Healthcare Sector Value Stocks

What Defines a Value Stock?

A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Below is a list of notable value stocks in the healthcare sector:

2 AIkido Pharma (NASDAQ:AIKI) - P/E: 3.26

4 Bio-Rad Laboratories (NYSE:BIO) - P/E: 5.19

6 Coherus BioSciences (NASDAQ:CHRS) - P/E: 8.47

8 Exagen (NASDAQ:XGN) - P/E: 0.31

10 OpGen (NASDAQ:OPGN) - P/E: 0.4

AIkido Pharma has reported Q3 earnings per share at -0.06, which has increased by 14.29% compared to Q2, which was -0.07. AIkido Pharma does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

Bio-Rad Laboratories saw an increase in earnings per share from 1.61 in Q2 to 3.0 now. Bio-Rad Laboratories does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

Coherus BioSciences has reported Q3 earnings per share at 0.47, which has decreased by 41.98% compared to Q2, which was 0.81. Coherus BioSciences does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

Exagen's earnings per share for Q3 sits at -0.34, whereas in Q2, they were at -0.27. Exagen does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

OpGen saw an increase in earnings per share from -0.49 in Q2 to -0.4 now. OpGen does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.